About: Plasma medicine: Opportunities for nanotechnology in a digital age

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Plasma medicine: Opportunities for nanotechnology in a digital age Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Plasma medicine: Opportunities for nanotechnology in a digital age
Creator	Liu, Dawei Ostrikov, Ken Kostya, \| Szili, Endre
Source	Medline; PMC
abstract	Advances in digital technologies have opened new opportunities for creating more reliable, time‐ and cost‐effective, safer and mobile methods of diagnosing, managing and treating diseases. A few examples of advanced nano‐ and digital technologies are already FDA‐approved for diagnosing and treating diseases. Plasma treatment is still emerging as a new healthcare technology, but it is showing a strong potential for treatment of many diseases including cancers and antimicrobial‐resistant infections, with little or no adverse side effects. Here, we argue that with the ever‐increasing complex healthcare challenges facing communities, including the ongoing COVID‐19 pandemic, it is critical to consider combining unique properties of emerging healthcare technologies into a single multimodal treatment modality that could lead to unprecedented healthcare benefits. In this article, we focus on the healthcare opportunities created by establishing a nexus between plasma, nano‐ and digital technologies. We argue that the combination of plasma, nano‐ and digital technologies into a single multimodal healthcare package may significantly improve patient outcomes and comfort, and reduce the economic burden on community healthcare, as well as alleviate many problems related to overcrowded healthcare systems.
has issue date	2020-07-09(xsd:dateTime)
bibo:doi	10.1002/ppap.202000097
bibo:pmid	32837492
has license	no-cc
sha1sum (hex)	d1167f0de66f66fc8e7c31bb6de476c64fd6b624
schema:url	https://doi.org/10.1002/ppap.202000097
resource representing a document's title	Plasma medicine: Opportunities for nanotechnology in a digital age
has PubMed Central identifier	PMC7361249
has PubMed identifier	32837492
schema:publication	Plasma Process Polym
resource representing a document's body	covid:d1167f0de66f66fc8e7c31bb6de476c64fd6b624#body_text
is schema:about of	named entity 'cancers' named entity 'Plasma' named entity 'diseases' named entity 'TIME' named entity 'PLASMA' named entity 'CANCERS' named entity 'DIAGNOSING' named entity 'INCLUDING' named entity 'TECHNOLOGY' named entity 'COST' named entity 'Plasma medicine' named entity 'medical treatments' named entity 'peroxynitrous acid' named entity 'research and development' named entity 'magnetic resonance imaging' named entity 'cross-disciplinary' named entity 'drug delivery' named entity 'wound healing' named entity 'general practitioner' named entity 'data processing' named entity 'diagnostic test' named entity 'nanotechnologies' named entity 'polymer' named entity 'biological target' named entity 'tumour' named entity 'synergistic effect' named entity 'microplasma' named entity 'oxidative stress' named entity 'nanotechnology' named entity 'glioblastoma' named entity 'plasmas' named entity 'electric field' named entity 'precision medicine' named entity 'Hyperthermia' named entity 'plasma technologies' named entity 'health care' named entity 'health care' named entity 'bacteria' named entity 'nanomaterials' named entity 'cell growth' named entity 'digital medicine' named entity 'personalised medicine' named entity 'COVID-19' named entity 'infection' named entity 'pathogens' named entity 'biomedical applications' named entity 'toxic effects' named entity 'cell membranes' named entity 'oncotherapies' named entity 'MRI' named entity 'tumour microenvironment' named entity 'wavelength' named entity 'plasma processing' named entity 'nanomedicines' named entity 'additive manufacturing' named entity 'Ultrasound' named entity 'nanotechnologies' named entity 'multiple myeloma' named entity 'nanoparticles' named entity 'reproducibility' named entity '1.2' named entity 'nanomedicine' named entity 'pathogen' named entity 'FDA' named entity 'SPECT' named entity 'plasma technologies' named entity 'Kaposi's sarcoma' named entity 'digital revolution' named entity 'digital printing' named entity 'reactive oxygen' named entity 'drug release' named entity 'viruses' named entity 'reversible process' named entity 'drug delivery systems' named entity 'plasma medicine' named entity 'interdisciplinary' named entity 'nanotechnologies' named entity 'DBD'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software